Allergic Rhinitis Drugs Market Report 2023-2033

ReportLinker
·7 min read
ReportLinker
ReportLinker

Forecasts by Treatment (Antihistamines, Immunotherapy (SCIT, SLIT), Corticosteroids, Decongestants, Others), by Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), by Route of Administration (Oral, Nasal, Intraocular, Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Allergic Rhinitis Drugs Market Report 2023-2033" - https://www.reportlinker.com/p06417092/?utm_source=GNW


The Allergic Rhinitis Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.


Advent of Innovative Intranasal Therapies for Treatment of Allergic Rhinitis

Intranasal therapies are gaining acceptance owing to their better safety and efficacy. This route of administration is also recommended by physicians and allergists since they do not have any systemic side-effects and their adequate concentrations can be achieved at receptor sides in nasal mucosa. Their adverse effects are limited to dryness, sneezing and stinging of nasal mucosa. Several companies are developing innovative intranasal drugs owing to their inherent advantages over other routes of administration. For instance, ClorNasal™ developed by Dr. Ferrer BioPharma is recognized as the best intranasal pharmacological formulation in the world. It is used in the treatment of several ailments including allergic rhinitis, Respiratory Syncytial Virus (RSV) Infection and COVID-19. Similarly, Altamira Therapeutics Ltd. Developed the nasal spray Bentrino. It prevents the onset of allergic symptoms by airborne allergens such as dust mites, and pollens.


Similarity of Symptoms With Other Diseases

Allergic rhinitis is an infection caused due to allergic reaction of immune system to an allergen. Some of the most common symptoms of allergic rhinitis include stuffy nose, watery eyes, itchy mouth, sneezing, post-nasal drip, sore throat, facial pain or pressure, partial loss of hearing, smell, and taste, and fatigue among others. The symptoms are very similar to cold and cough which might be caused by virus and not by any of the agents that cause allergies. The allergies can also trigger other conditions such as asthma, sinusitis, otitis media or eczema if not treatment well in time. Selection of the right drug candidate remains a major problem in the absence of accurate diagnosis. Administration of immunotherapy or allergy shots may have serious side effects such as hives and rash. It may sometimes have dangerous side effects such as anaphylaxis which may require years of treatment.


Adverse Effects of Drugs Used in Allergic Rhinitis Treatment

Allergic medications are mostly used over a long period of time to keep the lifestyle unaffected by different types of allergens in the environment. Antihistamines are the most widely used drug type for treatment of allergic infections. Some of the short-term side-effects of antihistamines include constipation, urinary retention, dry mouth, enhanced appetite, and worsen narrow-angle glaucoma. Several side-effects of nasal decongestants include high blood pressure, irritability, headache, and sleeplessness. Topical corticosteroids cause absorption of the drug into the systemic circulation which has potential to cause disturbance to the normal hormonal levels in the body. Corticosteroid ocular solutions can cause glaucoma, cataract and other eye infections. Intranasal corticosteroids can irritate nasal mucosa and also affect the cell lining of mouth and throat make them dry and soar. Oral corticosteroids are associated with side-effects such as osteoporosis, stomach ulceration, hyperglycaemia, increased blood pressure and muscle weakness.


What Questions Should You Ask before Buying a Market Research Report?

• How is the Allergic Rhinitis Drugs Market evolving?

• What is driving and restraining the Allergic Rhinitis Drugs Market?

• How will each Allergic Rhinitis Drugs submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each Allergic Rhinitis Drugs submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading Allergic Rhinitis Drugs Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the Allergic Rhinitis Drugs development projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of Allergic Rhinitis Drugs development projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the Allergic Rhinitis Drugs Market?

• Where is the Allergic Rhinitis Drugs Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?


You need to discover how this will impact the Allergic Rhinitis Drugs Market today, and over the next 10 years:

• Our 269-page report provides 105 tables and 173 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.


This report tells you TODAY how the Allergic Rhinitis Drugs Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.


Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of allergic rhinitis drugs and recent developments.


This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.


Segments Covered in the Report


Treatment Type

• Antihistamines

• Immunotherapy

- Subcutaneous Immunotherapy (SCIT)

- Sublingual Immunotherapy (SLIT)

• Corticosteroids

• Decongestants

• Others


Disease Type

• Seasonal Allergic Rhinitis

• Perennial Allergic Rhinitis

• Occupational Allergic Rhinitis


Route of Administration

• Oral

• Nasal

• Intraocular

• Intravenous


Distribution Channel

• Retail Pharmacies

• Hospital Pharmacies

• Online channels


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:


North America

• U.S.

• Canada


Europe

• Germany

• UK

• France

• Spain

• Italy

• Russia

• Rest of Europe


Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific


Latin America

• Brazil

• Mexico

• Rest of Latin America


MEA

• GCC

• South Africa

• Rest of MEA


The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, 2023 to 2033, with a focus on this segment of these companies’ operations.


Leading companies and the potential for market growth

• Alcon

• AstraZeneca

• Bayer AG

• Dr Reddy’s Laboratories

• GlaxoSmithKline PLC

• Johnson and Johnson

• Merck and Co

• Sanofi S.A.

• Sun Pharmaceuticals

• Teva Pharmaceutical Industries Ltd


Overall world revenue for Allergic Rhinitis Drugs Market, 2023 to 2033 in terms of value the market will surpass US$12,410 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.


How will the Allergic Rhinitis Drugs Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:


• Revenue forecasts to 2033 for Allergic Rhinitis Drugs Market, 2023 to 2033 Market, with forecasts for Type of Treatment, Disease, Route of Administration and Distribution channel at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.


• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Allergic Rhinitis Drugs Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.


• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Allergic Rhinitis Drugs Market, 2023 to 2033.


Read the full report: https://www.reportlinker.com/p06417092/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Latest Stories

  • Ukraine-Russia war – latest: Putin says he will deploy nuclear weapons in Belarus

    Russia has moved ten aircraft to Belarus that would be capable of carrying tactical nuclear weapons, president Putin claimed

  • Millions to get next cost-of-living payment from April

    From 25 April, millions of households on low incomes will get cost-of-living payments up to £900.

  • Assist of the Night: Deni Avdija

    Assist of the Night: Deni Avdija - March 26, 2023

  • 7 dead after explosion at Pennsylvania chocolate factory; cause remains under investigation

    Meanwhile, officials are still investigating what caused the explosion at the plant about 60 miles northwest of Philadelphia.

  • Avian Flu – Risk of Human Transmission Dubbed Low after Wild Birds Carrying Disease Found in Halton

    Halton Region Public Health has issued a warning to residents in Milton, Halton and other adjoining areas pertaining to the discovery of avian flu among dead birds in the region. While the disease usually affects wild birds, it can sometimes also reach commercial poultry and other animals. However, it is a rarity for the flu to spread to humans, with most cases emerging from close contact with infected poultry. The birds suspected of carrying avian influenza (H5N1) were wild, and regions across

  • APO Launches New Center of Excellence on Climate-smart Agriculture

    TOKYO, March 27, 2023--In efforts to enhance agricultural productivity, improve farmers' profits, and reduce greenhouse gas (GHG) emissions in the sector regionwide, the Asian Productivity Organization (APO) announced the designation of the National Agriculture and Food Research Organization (NARO) of Japan as its new Center of Excellence on Climate-smart Agriculture (COE on CSA). This is a result of the long-term partnership between the two institutions in disseminating know-how in the focus ar

  • The Blacklist recap: We're gonna talk about Bruno

    Red and the Task Force let Herbie take the lead.

  • LeBron James returns, but Lakers lose 118-108 to Bulls

    LOS ANGELES (AP) — LeBron James scored 19 points off the bench in his return from a monthlong injury absence, but Zach LaVine had 32 to lead the Chicago Bulls to a 118-108 victory over the Los Angeles Lakers on Sunday. DeMar DeRozan added 17 points for the Bulls, who easily overcame James’ return with an impressive performance in their seventh win in nine games. LaVine hit 11 of his first 14 shots to lead an offensive effort that snapped the Lakers’ three-game winning streak despite the return o

  • San Diego State, Miami adding to unique Final Four leads winners and losers from Sunday's Elite Eight

    There were highs and lows from Sunday's Elite Eight matchups that set the Final Four of the NCAA men's tournament. A look at the winners and losers.

  • WATCH: Morning showers Monday, warm afternoon

    WATCH: Morning showers Monday, warm afternoon

  • What the papers say – March 27

    Politics dominates the front pages at the start of the working week.

  • Parts of Twitter source code leaked online, court filing shows

    According to the filing, "various excerpts" of Twitter's source code, which is used to run the company online, were posted on Github, a Microsoft-owned platform for sharing code for software development, by a user named 'FreeSpeechEnthusiast'. Github said it took down the code on Friday at Twitter's request. Twitter has asked the U.S. District Court for the Northern District of California to order Github to produce "All identifying information" associated with the 'FreeSpeechEnthusiast' user name, the March 24 filing showed.

  • MSCHF's BWD Sneakers Can Be Worn Both Ways

    MSCHF, the Brooklyn-based creative studio famously known for its recently viral, Astro Boy-inspired...

  • Police seek information on hit and run crash

    Police seek information on hit and run crash

  • Man pulls owl out of chimney in Exeter

    One chimney sweep had an interesting day on the job in Exeter when he found an animal he's never come across in his work before.

  • NCAA Tournament - Looking ahead at next week's Final Four matchups

    Yahoo Sports writer Krysten Peek gives a preview of next week's Final Four matchups between San Diego State vs. FAU and UConn vs. Miami.

  • Asylum seekers continue to arrive at Roxham Road after closure

    Asylum seekers continue to show up at the Roxham Road irregular crossing into Quebec despite its closure under a new agreement between the U.S. and Canada. Many of them are still deciding to try to claim asylum in Canada but are being turned away.

  • At least 26 killed by tornadoes in southeast U.S.

    More than two dozen people in several U.S. states have been killed by tornadoes that have left some communities completely destroyed. Search and rescue efforts are now underway to find survivors.

  • Game Recap: Cavaliers 108, Rockets 91

    The Cavaliers defeated the Rockets 108-91. Jarrett Allen led Cleveland with 24 points, 14 rebounds, and three blocks as Donovan Mitchell added 22 points and five rebounds. Jalen Green led Houston with 30 points and four assists in the loss. With the win, the Cavaliers improve to 48-28 while the Rockets fall to 18-57 with the loss.With the victory, the Cavaliers have officially clinched a spot in the 2023 NBA Playoffs.

  • Game Recap: Magic 119, Nets 106

    Cole Anthony led Orlando with 21 points, six rebounds, and three assists as the Magic defeated the Nets 119-106 tonight in Orlando. Franz Wagner (19 points, 10 rebounds, six assists) and Wendell Carter Jr. (18 points, six rebounds) combined for 37 points for the Magic in the win. Mikal Bridges led the Nets with 44 points and six rebounds as Cam Thomas added 18 points in the loss. The Magic improve to 32-43 on the year, while the Nets fall to 40-35.